Technology for everyone?

Type 1 diabetes is one of the most common metabolic diseases in children and adolescents. A diagnosis of type 1 diabetes is a considerable burden for those affected and their families – especially when they are young. Further development of drug-based insulin and immunomodulatory therapies and increasing advances in technology mean that ever more innovative treatment options are available to achieve internationally defined target values. The most modern therapy currently available is the coupling of sensor system, control algorithm and insulin pump, the AID system (automated insulin delivery).